DRTG(SH:600329)2020-10-30 16:00Financial Performance - Operating income for the first nine months was ¥4,957,027,413.23, a decrease of 4.26% compared to the same period last year[5]. - Net profit attributable to shareholders of the listed company was ¥476,801,148.13, representing a year-on-year increase of 7.13%[5]. - Basic earnings per share for the period was ¥0.62, an increase of 6.90% compared to the same period last year[7]. - Total operating revenue for Q3 2020 reached ¥1,666,590,837.73, a slight increase from ¥1,643,758,662.99 in Q3 2019, representing a growth of approximately 1.1%[28]. - Net profit for Q3 2020 was ¥159,564,149.72, up from ¥99,603,218.54 in Q3 2019, indicating a significant increase of approximately 60.4%[29]. - The total profit for Q3 2020 was ¥182,366,018.87, compared to ¥151,729,282.02 in Q3 2019, indicating an increase of about 20.3%[29]. - The company's revenue for Q3 2020 was approximately ¥1.43 billion, a slight increase from ¥1.40 billion in Q3 2019, while the revenue for the first three quarters of 2020 was approximately ¥4.31 billion, down from ¥4.45 billion in the same period of 2019[31]. - The gross profit margin for Q3 2020 was approximately 33.4%, compared to 39.1% in Q3 2019, indicating a decrease in profitability[31]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥8,010,838,707.29, an increase of 2.14% compared to the end of the previous year[5]. - Total liabilities amounted to ¥2,233,692,541.25, down from ¥2,319,970,902.35, showing a decrease of around 3.72%[23]. - Current liabilities decreased to ¥2,071,369,392.33 from ¥2,157,206,952.90, reflecting a reduction of approximately 4.00%[22]. - The company's long-term equity investments decreased to ¥575,845,168.71 from ¥657,905,598.07 in December 2019[21]. - The company reported a significant increase in retained earnings, rising to ¥3,032,441,871.71 from ¥2,772,425,788.30, an increase of approximately 9.38%[23]. Cash Flow - Net cash flow from operating activities for the first nine months was ¥411,951,538.53, up 50.17% from the previous year[5]. - The net cash flow from operating activities improved by 50%, totaling ¥411,951,538.53 compared to ¥274,326,200.18 in the same period last year[17]. - Cash flow from operating activities for the first three quarters of 2020 was approximately ¥4.28 billion, down from ¥4.46 billion in the same period of 2019[34]. - The net cash flow from operating activities for the first three quarters was 408,992,110.30 RMB, an increase from 266,300,814.55 RMB year-over-year, reflecting improved operational performance[37]. - The net cash flow from investment activities was -371,289,197.88 RMB, compared to -42,763,973.00 RMB in the previous quarter, showing a worsening investment performance[35]. - The total cash inflow from investment activities was 13,589,167,500.19 RMB, significantly lower than 54,979,886,388.49 RMB in the previous quarter, indicating a decrease in investment recovery[35]. Shareholder Information - The total number of shareholders at the end of the reporting period was 35,192[11]. - The largest shareholder, Tianjin Pharmaceutical Group Co., Ltd., held 331,120,528 shares, accounting for 42.795% of the total shares[11]. - Shareholders' equity increased to ¥5,777,146,166.04 from ¥5,523,206,339.22, marking an increase of approximately 4.60%[23]. - Shareholders' equity increased to ¥5,628,735,992.30 from ¥5,355,279,942.83, marking an increase of approximately 5.1%[26]. Expenses and Income - The company reported a significant decrease in financial expenses, with a loss of ¥21,578,971.97, which is a 442% increase in income compared to the previous year[16]. - Other income increased by 133% to ¥21,332,506.29, primarily due to government subsidies[16]. - Research and development expenses for Q3 2020 were ¥28,874,204.75, compared to ¥25,974,256.51 in Q3 2019, representing an increase of about 11.2%[28]. - The company reported a decrease in sales expenses to ¥337,678,127.57 from ¥464,434,374.66 in Q3 2019, a reduction of approximately 27.3%[28]. - Investment income for Q3 2020 was approximately ¥44.01 million, an increase from ¥41.80 million in Q3 2019, reflecting improved investment performance[32]. - The company reported a significant increase in interest income, which was approximately ¥7.21 million in Q3 2020, compared to ¥3.05 million in Q3 2019[31].